Patient selection for the surgical treatment of resectable colorectal liver metastases
- PMID: 27778357
- DOI: 10.1002/jso.24482
Patient selection for the surgical treatment of resectable colorectal liver metastases
Abstract
Advances in surgery and chemotherapy regimens have increased the long-term survival of patients with colorectal liver metastases (CRLM). Although liver resection remains an essential part of any curative strategy for resectable CRLM, chemotherapy regimens have also improved the long-term outcomes. However, the optimal timing for chemotherapy regimens remains unclear. Thus, this review addressed key points to aid the decision-making process regarding the timing of chemotherapy and surgery for patients with resectable CRLM. J. Surg. Oncol. 2017;115:213-220. © 2016 Wiley Periodicals, Inc.
Keywords: chemotherapy; colorectal liver metastases; hepatectomy; long-term outcomes; surgery.
© 2016 Wiley Periodicals, Inc.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
